Forty-seven tumor samples (including ICC, PCC, DECC, GBC and metastasis) were examined and showed that decreased CDK10 mRNA occurred in 36 of the 47 samples (76.6%), compared with normal tissue (Fig. 1A). Here, CDK10 is linked to neoplasm.